PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-May-2021 Florence Announces $80 Million Series C Led by ScaleUp Investor Insight Partners Businesswire
06-May-2021 Infinity Announces the Date of Its First Quarter 2021 Financial Results Conference Call and Webcast Businesswire
06-May-2021 Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference Businesswire
06-May-2021 Axcella Reports First Quarter Financial Results and Provides Business Update Businesswire
06-May-2021 Virios Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on Thursday, May 13, 2021 Businesswire
06-May-2021 Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates Businesswire
06-May-2021 Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights Businesswire
06-May-2021 Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI‑powered Gene Therapy Platform Businesswire
06-May-2021 Can-Fite to Present at Benzinga’s Global Small Cap Conference on May 13, 2021 Businesswire
06-May-2021 ADC Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates Businesswire
06-May-2021 Aptorum Group Enters into an Agreement with Exeltis to Develop Aptorum’s Novel Preclinical Candidate Targeting Woman’s Gynecological Conditions Businesswire
06-May-2021 Ironwood Pharmaceuticals Reports First Quarter 2021 Results Businesswire
06-May-2021 Precision BioSciences to Report First Quarter 2021 Financial Results on May 13, 2021 Businesswire
06-May-2021 Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update Businesswire
06-May-2021 AdaptHealth Corp. Announces First Quarter 2021 Financial Results Businesswire
06-May-2021 The Coca-Cola Company Announces Expiration and Results of Debt Tender Offers Businesswire
06-May-2021 Merck and Eisai Receive Priority Review From FDA for KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Applications for Advanced Renal Cell Carcinoma and for Advanced Endometrial Carcinoma Businesswire
06-May-2021 Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games Businesswire
06-May-2021 Drug Farm Appoints Dr. Jeysen Yogaratnam as Chief Medical Officer Businesswire
06-May-2021 Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses Businesswire